Primate predictions

A team at Illumina Inc. (NASDAQ:ILMN) has developed an AI algorithm that will help identify pathogenic mutations from genome sequencing analyses by including non-human primate data in the training data set, and the approach could be used to identify new targets for personalized therapies.

The deep neural learning network, named PrimateAI, was described in a July Nature Genetics paper...